Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma

WEDNESDAY, Nov. 15, 2023 -- The addition of pembrolizumab to standard platinum-pemetrexed chemotherapy results in significant improvement in overall survival among patients with advanced pleural mesothelioma, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news